Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 1 X post from an account with 259 followers.

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells #amsm https://t.co/HTwhWdK6ei